This inventor holds 1 USPTO granted patent. Top assignee: Wyeth Holdings Corporation. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Innovations of Fang Fang Qi
Introduction
Fang Fang Qi is an accomplished inventor based in New City, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds aimed at inhibiting tumor growth. His work exemplifies the intersection of science and technology in the pursuit of medical advancements.
Latest Patents
Fang Fang Qi holds 1 patent for his invention titled "Crystalline forms of 5-chloro-6-{2,6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(1S)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine salts." This patent relates to the crystalline forms of the compound, processes for its production, pharmaceutical compositions, and methods for inhibiting tumor growth.
Career Highlights
Fang Fang Qi is currently employed at Wyeth Holdings Corporation, where he continues to innovate and contribute to the pharmaceutical industry. His expertise in the development of new compounds has positioned him as a valuable asset to his organization.
Collaborations
Fang Fang Qi has collaborated with notable colleagues, including Mannching Sherry Ku and David Michael Blum. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Fang Fang Qi's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to inspire future innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile